Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Safety Study of P28GST Treatment in Crohn's Disease Patients [Phase 2]
A Phase 2 safety study of P28GST in Crohn's disease patients has completed.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children [NA]
A pediatric Crohn's disease trial is evaluating the combination of infliximab with azathioprine; the study status is not yet recruiting.
-
EMA approval · 2026-02-19EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Hulio, a biosimilar of adalimumab, for multiple inflammatory indications including hidradenitis suppurativa, psoriasis, u…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Nutrition and Clinical Outcomes in IBD
This clinical trials update reports that the study 'Nutrition and Clinical Outcomes in IBD' is currently recruiting. It investigates nutriti…
-
EMA approval · 2026-02-18EMA Authorised: Wezenla (ustekinumab) — Amgen Technology (Ireland) UC
EU authorization for Wezenla, a ustekinumab product from Amgen Technology (Ireland) UC, indicated for psoriasis, psoriatic arthritis, and Cr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients [Phase 1]
A Phase 1 clinical trial update evaluating the safety and efficacy of CNK-UT009 in difficult-to-treat inflammatory bowel disease, including …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Study of Surgical Interventions in Fistulizing Conditions
Takeda sponsors a clinical trial evaluating surgical interventions for fistulizing disease, including Crohn's disease with fistulas; the stu…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease [Phase 4]
A Phase 4 clinical trial is evaluating a combination of palmitoleic acid with infliximab to promote intestinal mucosal healing in Crohn's di…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy
A completed clinical trial evaluated tissue cytomegalovirus viral load and associated factors in pediatric patients undergoing colonoscopy, …
-
EMA approval · 2026-02-17EMA Authorised: Usrenty (ustekinumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Usrenty (ustekinumab biosimilar) by Biosimilar Collaborations Ireland Limited for Crohn's disease.
-
EMA approval · 2026-02-17EMA Authorised: Inflectra (infliximab) — Pfizer Europe MA EEIG
EMA authorised Inflectra (infliximab) as a biosimilar to Remicade for multiple inflammatory diseases including rheumatoid and psoriatic arth…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease [Phase 4]
A Phase 4 clinical trial is evaluating whether combining Akkermansia muciniphila with infliximab can promote intestinal mucosal healing in C…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease [NA]
This ClinicalTrials.gov update describes a pilot study to evaluate the safety, tolerability, and efficacy of virtual reality therapy for abd…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
This clinical trial update describes evaluating a switch from intravenous to subcutaneous vedolizumab for inflammatory bowel disease, includ…
-
EMA approval · 2026-02-16EMA Authorised: Yesintek (ustekinumab) — Biosimilar Collaborations Ireland Limited
The European Medicines Agency authorised Yesintek, a biosimilar of ustekinumab, for use in psoriasis, psoriatic arthritis, and Crohn's disea…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Comparison of the Therapeutic Effects of Balloon Assisted Enteroscopy Assisted Narrow Incision and Balloon Dilation in the Treatment of Crohn's Disease Small Intestinal Stenosis [NA]
This clinical trial compares balloon-assisted enteroscopy with narrow incision to balloon dilation for Crohn's disease-related small intesti…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
A prospective observational study to evaluate early response to vedolizumab and IL-23 antagonists in participants with Crohn's disease; the …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Standardized Microbiota Transplant Therapy in Crohn's Disease [Phase 2]
This clinical trial update concerns a Phase 2 study of standardized microbiota transplant therapy for Crohn's disease. The trial is currentl…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases
A clinical trial is recruiting to assess whether a structured therapeutic education session increases participation in adapted physical acti…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
A clinical trial (SHIFT-IBD) is evaluating switching to the IL-23 inhibitor guselkumab in active inflammatory bowel disease patients who pre…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
A clinical trial is evaluating the ALPCO Calprotectin CLIA assay to determine expected calprotectin values in healthy subjects; the study is…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease [NA]
A clinical trial evaluating Efferon LPS for Crohn's disease and ulcerative colitis is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
A clinical trial evaluating the ALPCO Calprotectin CLIA assay for measuring calprotectin levels in human stool in inflammatory bowel disease…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease [EARLY_Phase 1]
Early-phase 1 clinical trial investigating 68Ga-FAPI-46 PET/CT for assessing small bowel fibrostenosis in Crohn's disease is currently recru…
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: ACT for Veterans With IBD and Mental Health Challenges [NA]
ClinicalTrials.gov update describes a not-yet-recruiting study evaluating Acceptance and Commitment Therapy for veterans with inflammatory b…